Results 151 to 160 of about 52,980 (203)

Commentary: Beneficial non-specific effects of measles vaccine: Fact or fiction? [PDF]

Hum Vaccin Immunother
Aaby P, Nielsen S, Schaltz-Buchholzer F, Martins C, Benn CS.   +4 more
europepmc   +1 more source

Vaccination

BMJ
openaire   +3 more sources

Immunogenicity and safety of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults ≥18 years of age in India: A phase 3 single-arm trial. [PDF]

Hum Vaccin Immunother
Giriappa B, Choraria N, Ponce P, Drozd J, Su X, Lei L, Portka M, Pai S, Anderson A, Bickham K, Watson W, McElwee K.   +11 more
europepmc   +1 more source

A commentary on measles vaccine in the context of outbreaks: Viral evolution, waning immunity and public trust. [PDF]

Hum Vaccin Immunother
Equils O, Kuliyev T, Hoang A, Tafuri S.
europepmc   +1 more source

Commentary: Improving the vaccination experience for children and adults. [PDF]

Hum Vaccin Immunother
Rand CM, Szilagyi PG.
europepmc   +1 more source

Epizootie de peste bovine en Adamaoua (République du Cameroun) [PDF]

, 1961
Blanc, Robert
core  

Closing the hepatitis B birth-dose gap in Cameroon: Global evidence and policy imperatives. [PDF]

Hum Vaccin Immunother
Akem TE.
europepmc   +1 more source

La péripneumonie bovine : étude et mise au point de l'ovo-vaccin antiperipneumonique [PDF]

, 1961
Mémery, Georges, Orue, Jean
core  

Pneumococcal vaccination offer and schedules in adults in EU countries: An update. [PDF]

Hum Vaccin Immunother
Chiavarini M, Boccalini S, Bechini A, Barash A, Castellana E, Senape A, Bonanni P.   +6 more
europepmc   +1 more source

Access to a protected setting vaccination for allergic patients: Evaluation of appropriateness. The experience of Bari Policlinico University Hospital. [PDF]

Hum Vaccin Immunother
Di Lorenzo A, De Petro P, Leone F, Germinario CA, Tafuri S, Stefanizzi P.   +5 more
europepmc   +1 more source